Issue Archive
|
Subscribe
|
Editorial Board
|
About
|
Contact
|
Advertise
Home
News
News in Brief
Doctors in the News
FDA News
Industry News
Drugs in the Pipeline
Daily Nephrology News
Daily Urology News
Newsletters
Urology
Bladder Cancer
Benign Prostatic Hyperplasia
Erectile Dysfunction
Hypogonadism
Kidney Cancer
Kidney Stones
Overactive Bladder
Premature Ejaculation
Prostate Cancer
Prostate Specific Antigen
Reproductive Medicine
Urinary Incontinence
Nephrology
Acute Kidney Injury
Acute Renal Failure
Anemia
Chronic Kidney Disease
Contrast Nephropathy
Cardiovascular Disease
Diabetes
Diabetic Nephropathy
Focal Segmental Glomerulosclerosis
Hemodialysis
Hyperphosphatemia
Hypertension
Hyperuricemia
Kidney Cancer
Kidney Stones
Lupus Nephritis
Peritoneal Dialysis
Secondary Hyperparathyroidism
Transplantation
Departments
On The Forefront
Your Practice
Your Money
Legal Issues in Medicine
Malpractice News
Video Interviews
World Literature Review
Conferences
Meetings Calendar
Genitourinary Cancers Symposium
Kidney Week 2011
International Continence Society
AUA 2011
NKF 2011
ERA-EDTA 2011 Congress
American Transplant Congress
World Congress of Nephrology
Annual Dialysis Conference
EAU Annual Congress
AUA Annual Meeting
ASH Annual Meeting
Canadian Urological Association Annual Meeting
NKF 2010 Spring Meetings
NKF 2009
Renal Week 2010
Renal Week 2009
Renal Week 2008
Clinical Trials
Acute Kidney Injury
Bladder Cancer
Diabetes Mellitus
Hemodialysis
Hyperphosphatemia
Kidney/Ureteral Stones
Lupus Nephritis
Nephrogenic Systemic Fibrosis
Overactive Bladder
Pelvic Prolapse
Prostate Cancer
Renal Cell Carcinoma
Renal Obstruction
Renal Transplant
Voiding Dysfunction
Directories
Nephrology Buyer's Guide
Urology Buyer's Guide
Dialysis Directory
CME
CME Articles
mycme.com
Resources
View Full Issue
Links
Crossword Puzzles
Clinical Quiz
Cartoons
Expert Q&A
Renal Nutrition Update
Commentary
Features
Medical Minute
Polls
Drug Info
Jobs
RSS
|
Login
|
Register
RUN
>
Departments
>
Ongoing Clinical Trials
> Overactive Bladder Clinical Trials
Overactive Bladder Clinical Trials
Urinary Nerve Growth Factor (NGF), Prostaglandin E2 (PGE2)and Adenosine Triphosphate (ATP): Potential Biomarkers in Overactive Bladder Patients
Therapy of the Overactive Bladder Syndrome (TOBS)
A Study of the Pharmacokinetics and Pharmacodynamics of MK4618 in Women With Overactive Bladder (MK-4618-004)
Trospium Chloride XR in Obese Female Patients With Overactive Bladder
Evaluation of Autonomic System Before and After Anticholinergic Treatment in Women With Overactive Bladder
A Phase 2 Study to Compare the Efficacy and Tolerability of Tarafenacin 0.2 mg and Tarafenacin 0.4 mg to Placebo Administered as Oral Daily Dose for Three Months in Patients Suffering From Overactive Bladder
Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Neurogenic Overactive Bladder
Comparison of Motor and Sensory Response With Interstim Stimulation
Effects of Antimuscarinic Drugs on Overactive Bladder (OAB) Symptoms After Insertion of Ureteral Stents
A Prospective, Multi-center, Placebo-controlled, Randomized, Double-blind, Phase 2 Study to Compare the Efficacy and Tolerability of Tarafenacin 0.2 mg and Tarafenacin 0.4 mg to Placebo Administered as Oral Daily Dose for Three Months in Patients Suffering
Botox for the Treatment of Overactive Bladder Secondary to Benign Prostatic Obstruction
Post Marketing Surveillance Of Fesoterodine In Filipino Patients With Over Active Bladder
The Effect of Position on Urge Sensation in Volunteers and in Patients With Overactive Bladder Syndrome
Efficacy Study of Adalimumab to Treat Interstitial Cystitis
A Study to Evaluate the Efficacy, Safety and Tolerability of Mirabegron and Solifenacin Alone and in Combination for the Treatment of Overactive Bladder (Symphony)
Evaluating the Treatment of Overactive Bladder Symptoms in Women Post Pubovaginal Sling Procedure
A Study of the Efficacy and Safety of MK-4618 in Patients With Overactive Bladder (OAB) (MK-4618-008 AM1 EXT)
Combination Treatment With Doxazosin Plus TolterodineSR 2 mg Versus 4mg in Men With an Overactive Bladder (OAB) and Benign Prostatic Hyperplasia (BPH)
A 12 Week Study to Confirm the Effectiveness of 8mg of Fesoterodine Compared to 4mg of Fesoterodine
Local, Open-Label, Extension Trial Of The Efficacy And Safety Of Fesoterodine In Elderly Patients With Overactive Bladder
Combined Behavioral and Drug Treatment of Overactive Bladder in Men (COBALT)
Safety and Effectiveness of a Non-invasive Neuromodulation Device on Urgency Urinary Incontinence in Overactive Bladder (Beacon)
Effects and Safety of Liposome Encapsulated Botulinum Toxin A for Overactive Bladder Syndrome
Comparison of Solifenacin and Oxybutynin in the Treatment of Overactive Bladder
Comparative Urine Proteomic Studies of Overactive Bladder in Humans
A Clinical Study in Patients With Overactive Bladder With Leakage of Urine, to Find Out if the Medicine, Fesoterodine, Works in Those Patients Who Did Not Have Enough Response to the Medicine, Tolterodine.
Grouptraining for Overactive Bladder in Adults
Web-based Methodology Trial to Evaluate the Efficacy and Safety of Tolterodine ER in Subjects With Overactive Bladder (REMOTE)
Solifenacin Succinate (VESIcare) for the Treatment of Overactive Bladder in Parkinson's Disease (URGE-PD)
Comparison of Caffeine Reduction and Anticholinergic Medications for Treatment of Overactive Bladder
Overactive Bladder News
Repeated Toxin Injections Safe and Effective for Refractory Overactive Bladder
Overactive Bladder Linked to Metabolic Syndrome in Women
Approval Sought for New Overactive Bladder Drug
more »
Latest CME Article
Renal & Urology News
includes a CME article in every print issue, which will also be available online.
View the latest installment:
An Update on Robotic-Assisted Partial Nephrectomy
Cartoons
Click here for our latest cartoons
Subscribe to the RSS for this page [
view all our RSS feeds here
]
Most Popular
Most Emailed
Most Recent
Very Low Testosterone Hikes Prostate Cancer Recurrence Risk
Herbal Product May Be Useful for Recurrent Prostate Cancer
Empiric Antibiotics for Elevated PSA of No Clinical Benefit
Prostate Cancer Linked to Heavy Alcohol Intake
Proton Therapy No Better than IMRT for Prostate Cancer
First PSA Results Predict Long-Term Prostate Cancer Risk
Novel Drug Prolongs Survival in Men with Advanced Prostate Cancer
Let Patients Sleep During Rounds
Many Metastatic Prostate Cancers Go Untreated
Exercise Enhances Body Composition, Nutritional Status in Dialysis Patients
Proton Therapy No Better than IMRT for Prostate Cancer
First PSA Results Predict Long-Term Prostate Cancer Risk
Empiric Antibiotics for Elevated PSA of No Clinical Benefit
Prostate Cancer Linked to Heavy Alcohol Intake
Novel Drug Prolongs Survival in Men with Advanced Prostate Cancer
Herbal Product May Be Useful for Recurrent Prostate Cancer
Similar Outcomes Found with Open, Robotic Cystectomy
Let Patients Sleep During Rounds
Very Low Testosterone Hikes Prostate Cancer Recurrence Risk
Prostate Cancer Patients Far More Likely to Die from Other Causes
Substances in Coffee May Prevent, Treat Diabetes
Circulating Tumor Cells Predict Worse Outcomes in Bladder Cancer Patients
Similar Outcomes Found with Open, Robotic Cystectomy
Never-Married Men Fare Worse After Prostate Cancer Surgery
Very Low Testosterone Hikes Prostate Cancer Recurrence Risk
Brachytherapy May Be An Option for Men with High-Risk Prostate Cancer
Prostate Cancer Linked to Heavy Alcohol Intake
PSA Testing Rates Unchanged for Elderly Men Despite Task Force Guidelines
Prostate Cancer Patients Far More Likely to Die from Other Causes
Many Metastatic Prostate Cancers Go Untreated
Popular Topics
Acute Kidney Injury
Anemia
Bladder Cancer
BPH
Cardiovascular Disease
Chronic Kidney Disease
CKD
Diabetes
Epidemiology
Erectile Dysfunction
Hemodialysis
Hyperphosphatemia
Hypertension
Infection
Kidney Cancer
Kidney Stones
Nutrition
Overactive Bladder
Peritoneal Dialysis
Prostate Cancer
PSA
Reproductive Medicine
Transplantation
Urinary Incontinence
UTI